ODN 1668 is a synthetic oligodeoxynucleotide (ODN) containing CpG motifs and acts as an agonist of Toll-like receptor 9 (TLR9)[1]. CpG ODN 1668 has been reported to enhance the antibacterial effects of Rhamdia quelen against Aeromonas hydrophila infection[2].
In vitro, ODN 1668 (2μg/ml; 12h) significantly enhances the antibacterial immunity of head kidney lymphocytes (HKLs). In addition, ODN 1668 (0, 0.175, 0.25, 0.5, 1, 2, 4, 8, 16 and 32μg/ml; 12h) also promotes the cell proliferation and immune gene expression of HKLs, and strengthens the phagocytic activity of head kidney macrophages[3]. Stimulation of macrophages with ODN 1668 (1μM; 6h) increases the production of the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL-1Ra) in a Toll-like receptor 9 (TLR9) and MyD88-dependent manner, thereby enhancing macrophage migration and promoting macrophage proliferation[4].
In vivo, ODN 1668 (15μg/fish; 24h; i.m.) significantly enhances the antibacterial immune response in humpback grouper[3]. Administration of a Toll-like receptor 9 (TLR9) agonist ODN 1668 (10μg/kg/weekly; 8 weeks; i.v.) to apolipoprotein E-deficient (ApoE-/-) mice resulted in a reduction of atherosclerotic lesion severity[5].
References:
[1] Damm J, Wiegand F, Harden LM, Wenisch S, Gerstberger R, Rummel C, Roth J. Intraperitoneal and subcutaneous injections of the TLR9 agonist ODN 1668 in rats: brain inflammatory responses are related to peripheral IL-6 rather than interferons. J Neuroimmunol. 2014 Dec 15;277(1-2):105-17.
[2] Canova, Raíssa, Kirsten K S , Lucas D F S ,et al.Oligodeoxynucleotides CpGs increase silver catfish (Rhamdia quelen) resistance to Aeromonas hydrophila challenge[J].Aquaculture, 2017, 473:278-282.
[3] Chen X, Zhang P, Li P, Wang G, Li J, Wu Y, Cao Z, Zhou Y, Sun Y. CpG ODN 1668 as TLR9 agonist mediates humpback grouper (Cromileptes altivelis) antibacterial immune responses. Fish Shellfish Immunol. 2023 Jul;138:108839.
[4] Chen TA, Liao CC, Cheng YC, Chen YP, Hsu YF, Liang CM, Liang SM. Stimulation of Proliferation and Migration of Mouse Macrophages by Type B CpG-ODNs Is F-Spondin and IL-1Ra Dependent. PLoS One. 2015 Jun 4;10(6):e0128926.
[5] Koulis C, Chen YC, Hausding C, Ahrens I, Kyaw TS, Tay C, Allen T, Jandeleit-Dahm K, Sweet MJ, Akira S, Bobik A, Peter K, Agrotis A. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):516-25.
ODN 1668是一种含有CpG基序的合成寡脱氧核苷酸(ODN),是Toll样受体9(TLR9)的激动剂[1]。CpG ODN 1668已被报道能够增强银尾鲶(Rhamdia quelen)抵抗嗜水气单胞菌(Aeromonas hydrophila)感染的抗菌效果[2]。
在体外实验中,ODN 1668(2μg/ml; 12h)显著增强了头部肾脏淋巴细胞(HKLs)的抗菌免疫能力[3]。此外,ODN 1668(0, 0.175, 0.25, 0.5, 1, 2, 4, 8, 16和32μg/ml; 12h)还促进了头部肾脏淋巴细胞的细胞增殖和免疫基因表达,并增强了头部肾脏巨噬细胞的吞噬活性[3]。用ODN 1668(1μM; 6h)刺激巨噬细胞,能够通过依赖Toll样受体9(TLR9)和髓样分化因子88(MyD88)的方式,增加抗炎细胞因子白细胞介素1受体拮抗剂(IL-1Ra)的产生,从而增强巨噬细胞的迁移能力并促进其增殖[4]。
在体内实验中,ODN 1668(15μg/尾; 24h; 肌肉注射)显著增强了斜带石斑鱼的抗菌免疫反应[3]。向载脂蛋白E缺陷(ApoE-/-)小鼠给予Toll样受体9(TLR9)激动剂ODN 1668(10μg/kg/每周一次; 8周; 静脉注射)后,动脉粥样硬化病变的严重程度有所减轻[5]。
















